RESÚMENES NOVIEMBRE 2008

.

Mood - Anxiety Disorders & Antidepressants – Mood Stabilizers

(Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

GRATIS = Texto gratuito en algunos países de la región iberoamericana (algunos artículos requieren ir a la tabla de contenidos del número actual de la revista)

 

3 - Heart Rate Variability in Depressed Elderly

Ripu D. Jindal, Raymond C. Vasko Jr, J. Richard Jennings, Amy L. Fasiczka, Michael E. Thase, and Charles F. Reynolds III

Am J Geriatr Psychiatry 16:861-866, November 2008

3 - Decreased Heart Rate Variability is Associated with Poststroke Depression

Robert G. Robinson, Gianfranco Spalletta, Ricardo E. Jorge, Andrea Bassi, Furio Colivicchi, Alessandra Ripa, and Carlo Caltagirone

Am J Geriatr Psychiatry 16:867-873, November 2008

3! - Prescription Patterns of Psychotropic Medications in Elderly Compared With Younger Participants Who Achieved a "Recovered" Status in the Systematic Treatment Enhancement Program for Bipolar Disorder

Rayan K. Al Jurdi, Lauren B. Marangell, Nancy J. Petersen, Melissa Martinez, Laszlo Gyulai, and Martha Sajatovic

Am J Geriatr Psychiatry 16:922-933, November 2008

5 - Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder

Stuart Montgomery, Krai Chatamra, Lynne Pauer, Ed Whalen, Francesca Baldinetti

The British Journal of Psychiatry (2008) 193: 389-394

3! - Serotonin Syndrome Risks When Combining SSRI/SNRI Drugs and Triptans: Is the FDA's Alert Warranted?

Richard G Wenzel, Stewart Tepper, William E Korab, Fredrick Freitag

The Annals of Pharmacotherapy: Vol. 42, No. 11, pp. 1692-1696

3 - The management of depression: An international naturalistic survey

Yves Lecrubier;  Won-Myong Bahk;  Jose De Matos; Mike Briley

International Journal of Psychiatry in Clinical Practice, Volume 12, Issue 4 2008, pages 285 - 291

 

3! - Generalized anxiety disorder and the circadian rhythm of blood pressure in patients with hypertension

Long-Le Ma;  De-Gui Kong;  Xue-Wen Qi; Le-Xin Wang

International Journal of Psychiatry in Clinical Practice, Volume 12, Issue 4 2008, pages 292 - 295

 

5< - A double-blind comparative study of clinical efficacy of verapamil versus lithium in acute mania

Gurvinder Pal Singh

International Journal of Psychiatry in Clinical Practice, Volume 12, Issue 4 2008, pages 303 - 308

 

3! - An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder

Leuchter AF, Lesser IM, Trivedi MH, Rush AJ, Morris DW, Warden D, Fava M, Wisniewski SR, Luther JF, Perales M, Gaynes BN, Stewart JW

J Psychiatr Pract. 2008 Sep;14(5):271-80

 

3! - Does Bereavement-Related Major Depression Differ From Major Depression Associated With Other Stressful Life Events?

Kenneth S. Kendler, John Myers, Sidney Zisook

Am J Psychiatry 2008; 165:1449-1455

5 - Homocysteine and Depression in Later Life

Osvaldo P. Almeida, Kieran McCaul, Graeme J. Hankey, Paul Norman, Konrad Jamrozik, Leon Flicker

Arch Gen Psychiatry. 2008;65(11):1286-1294

 

3! - Discontinuation of Maintenance Selective Serotonin Reuptake Inhibitor Monotherapy After 5 Years of Stable Response: A Naturalistic Study

Tara M. Pundiak, Brady G. Case, Eric D. Peselow, and Loretta Mulcare

J Clin Psychiatry November 4, 2008: e1-e7

 

3 - Paroxetine: safety and tolerability issues

David M Marks, Min-Hyeon Park, Byung-Joo Ham, Changsu Han, Ashwin A Patkar, Prakash S Masand & Chi-Un Pae

Expert Opinion on Drug Safety. November 2008, Vol. 7, No. 6, Pages 783-794

 

3! - Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons

Alessia Bachis, Alessandra Mallei, Maria Idalia Cruz, Anton Wellstein and Italo Mocchetti

Neuropharmacology. Volume 55, Issue 7, December 2008, Pages 1114-1120

 

3! - Sustained administration of bupropion alters the neuronal activity of serotonin, norepinephrine but not dopamine neurons in the rat brain

Mostafa El Mansari, Ramez Ghanbari, Shannon Janssen and Pierre Blier

Neuropharmacology. Volume 55, Issue 7, December 2008, Pages 1191-1198

 

3 - Housing conditions modulate escitalopram effects on antidepressive-like behaviour and brain neurochemistry

Astrid Bjørnebekk, Aleksander A. Mathé, Susanne H. M. Gruber and Stefan Brené

The International Journal of Neuropsychopharmacology (2008), 11:1135-1147

 

5 - A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression

André Russowsky Brunoni, Mariana Lopes and Felipe Fregni

The International Journal of Neuropsychopharmacology (2008), 11:1169-1180

 

3! - Severely Depressed Young Patients Have Over Five Times Increased Risk for Stroke: A 5-Year Follow-Up Study

Hsin-Chien Lee, Herng-Ching Lin and Shang-Ying Tsai

Biological Psychiatry. Volume 64, Issue 10, 15 November 2008, Pages 912-915 

3! - Antidepressant Use, Depression, and Survival in Patients With Heart Failure

Christopher M. O’Connor, Wei Jiang, Maragatha Kuchibhatla, Rajendra H. Mehta, Greg L. Clary, Michael S. Cuffe, Eric J. Christopher, Jude D. Alexander, Robert M. Califf, Ranga R. Krishnan

Arch Intern Med. 2008;168(20):2232-2237

 

3 - Ziprasidone in the Treatment of Affective Disorders: A Review

Adriane R Rosa, Carolina Franco, Carla Torrent, Mercè Comes, Nuria Cruz, Guillermo Horga, Antonio Benabarre & Eduard Vieta

CNS Neuroscience & Therapeutics. Volume 14 Issue 4, Pages 278 - 286

 

5 - Does Randomized Evidence Support Sertraline as First-Line Antidepressant for Adults With Acute Major Depression? A Systematic Review and Meta-Analysis

Andrea Cipriani, Toshiaki A. Furukawa, John R. Geddes, Lara Malvini, Alessandra Signoretti, Hugh McGuire, Rachel Churchill, Atsuo Nakagawa,.; and Corrado Barbui, on behalf of the MANGA Study Group

J Clin Psychiatry November 4, 2008: e1-e11

 

3! - Antidepressant drugs and cardiovascular pathology: a clinical overview of effectiveness and safety

D. Taylor

Acta Psychiatrica Scandinavica. Volume 118 Issue 6, Pages 434 - 442

 

3! - The impact of clinical significance criteria on subthreshold depression prevalence rates

H. Baumeister, V. Morar

Acta Psychiatrica Scandinavica. Volume 118 Issue 6, Pages 443 - 450

 

3! - Prevalence, onset and comorbidity of postpartum anxiety and depressive disorders

C. Reck, K. Struben, M. Backenstrass, U. Stefenelli, K. Reinig, T. Fuchs, C. Sohn, C. Mundt

Acta Psychiatrica Scandinavica. Volume 118 Issue 6, Pages 459 - 468

 

5 - Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial

E. Lauterbach, W. Felber, B. Müller-Oerlinghausen, B. Ahrens, T. Bronisch, T. Meyer, B. Kilb, U. Lewitzka, B. Hawellek, A. Quante, K. Richter, A. Broocks, F.Hohagen

Acta Psychiatrica Scandinavica. Volume 118 Issue 6, Pages 469 - 479

 

3 - Depressive Symptoms and Serum Lipid Fractions in Middle-Aged Men: Physiologic and Health Behavior Links

Cornel Victor Igna, Juhani Julkunen, Hannu Vanhanen, Pertti Keskivaara, and Markku Verkasalo

Psychosomatic Medicine 70:960-966 (2008)

3 - Depressed Mood, Positive Affect, and Heart Rate Variability in Patients With Suspected Coronary Artery Disease

Mimi R. Bhattacharyya, Daisy L. Whitehead, Roby Rakhit, and Andrew Steptoe

Psychosomatic Medicine 70:1020-1027 (2008)

3 - Antidepressants Targeting the Serotonin Reuptake Transporter Act via a Competitive Mechanism

Subbu Apparsundaram, Daniel J. Stockdale, Robert A. Henningsen, Marcos E. Milla, and Renee S. Martin

JPET 327:982-990, 2008

 

3 - Desvenlafaxine Extended Release

Yang, Lily P H; Plosker, Greg L

CNS Drugs. 22(12):1061-1069, 2008

3 - Nutrition and depression: A review of the evidence

Lynn Harbottle; Nicola Schonfelder

Journal of Mental Health, Volume 17, Issue 6 December 2008, pages 576 - 587

 

3 - Responsiveness of sensorimotor cortex during pharmacological intervention with bromazepam

Marlo Cunha, Cláudio Portela, Victor H. Bastos, Dionis Machado, Sergio Machado, Bruna Velasques, Henning Budde, Maurício Cagy, Luis Basile, Roberto Piedade and Pedro Ribeiro

Neuroscience Letters. Volume 448, Issue 1, 19 December 2008, Pages 33-36

 

5 - An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder

Preskorn, Sheldon H; Baker, Bryan; Kolluri, Sheela; Menniti, Frank S; Krams, Michael; Landen, Jaren W

Journal of Clinical Psychopharmacology. 28(6):631-637, December 2008

3 - Pharmacokinetics of Sertraline Across Pregnancy and Postpartum

Freeman, Marlene P; Nolan, Paul E. Jr; Davis, Melinda F; Anthony, Marietta; Fried, Karen; Fankhauser, Martha; Woosley, Raymond L; Moreno, Francisco

Journal of Clinical Psychopharmacology. 28(6):646-653, December 2008

3 - A UK consensus on the administration of aripiprazole for the treatment of mania

KJ Aitchison, M Bienroth, J Cookson, R Gray, PM Haddad, B Moore, L Ratna, G Sullivan, D Taylor, M Taylor, and GM Goodwin

Journal of Psychopharmacology. First published on November 14, 2008

3! - Changes in Thalamus–Hypothalamus Serotonin Transporter Availability during Clomipramine Administration in Patients with Obsessive–Compulsive Disorder

Werner Zitterl, Martin Aigner, Thomas Stompe, Karin Zitterl-Eglseer, Karin Gutierrez-Lobos, Thomas Wenzel, Georg Zettinig, Kurt Hornik, Walter Pirker and Kenneth Thau

Neuropsychopharmacology (2008) 33, 3126–3134

 

3! - Clomipramine In Vitro Reduces Glucocorticoid Receptor Function in Healthy Subjects but not in Patients with Major Depression

Livia A Carvalho, Mario F Juruena, Andrew S Papadopoulos, Lucia Poon, Rob Kerwin, Anthony J Cleare and Carmine M Pariante

Neuropsychopharmacology (2008) 33, 3182–3189

 

3 - Norepinephrine Transporter Regulation Mediates the Long-Term Behavioral Effects of the Antidepressant Desipramine

Zaorui Zhao, Alicia M Baros, Han-Ting Zhang, M Danet S Lapiz, Corina O Bondi, David A Morilak and James M O'Donnell

Neuropsychopharmacology (2008) 33, 3190–3200

 

5 - Estimates of Serotonin and Norepinephrine Transporter Inhibition in Depressed Patients Treated with Paroxetine or Venlafaxine

Michael J Owens, Stan Krulewicz, Jeffrey S Simon, David V Sheehan, Michael E Thase, David J Carpenter, Susan J Plott and Charles B Nemeroff

Neuropsychopharmacology (2008) 33, 3201–3212

 

5 - Acute 5-HT Reuptake Blockade Potentiates Human Amygdala Reactivity

Kristin L Bigos, Bruce G Pollock, Howard J Aizenstein, Patrick M Fisher, Robert R Bies and Ahmad R Hariri

Neuropsychopharmacology (2008) 33, 3221–3225

 

3 - The implications of gene–environment interactions in depression: will cause inform cure?

R Uher

Molecular Psychiatry (2008) 13, 1070–1078

 

GRATIS (previo registro) 3 - Estimulación cerebral profunda para el tratamiento de la depresión resistente

C.V. Torres, A.M. Lozano

REV NEUROL 2008;47:477-482

 

GRATIS (previo registro) 3! - Opciones terapéuticas en las depresiones vasculares

Pelegrín-Valero, C.; Benabarre-Ciria, S.; Olivera-Pueyo, J

PSICOGERIATRIA 2008; 0: 35-42

 

GRATIS 3 - Using Second-Generation Antidepressants to Treat Depressive Disorders: A Clinical Practice Guideline from the American College of Physicians

Amir Qaseem, Vincenza Snow, Thomas D. Denberg, Mary Ann Forciea, Douglas K. Owens, for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians
Annals. 18 November 2008 | Volume 149 Issue 10 | Pages 725-733

 

GRATIS 5 - Comparative Benefits and Harms of Second-Generation Antidepressants: Background Paper for the American College of Physicians

Gerald Gartlehner, Bradley N. Gaynes, Richard A. Hansen, Patricia Thieda, Angela DeVeaugh-Geiss, Erin E. Krebs, Charity G. Moore, Laura Morgan, and Kathleen N. Lohr

Annals. 18 November 2008 | Volume 149 Issue 10 | Pages 734-750

 

3! - Correlates of Treatment-Emergent Mania Associated With Antidepressant Treatment in Bipolar Depression

Mark A. Frye, Gerhard Helleman, Susan L. McElroy, Lori L. Altshuler, David O. Black, Paul E. Keck , Jr., Willem A. Nolen, Ralph Kupka, Gabriele S. Leverich, Heinz Grunze, Jim Mintz, Robert M. Post, and Trisha Suppes

Am J Psychiatry Published November 17, 2008

GRATIS 3 - Revisiting the Dexamethasone Suppression Test in unipolar major depression: an exploratory study

Konstantinos N Fountoulakis, Xenia Gonda, Zoltan Rihmer, Costas Fokas and Apostolos Iacovides

Annals of General Psychiatry 2008, 7:22

 

3! - Dysfunctional attitudes and perceived stress predict depressive symptoms severity following antidepressant treatment in patients with chronic depression

Paola Pedrelli, Greg C. Feldman, Sienna Vorono, Maurizio Fava and Timothy Petersen

Psychiatry Research. Volume 161, Issue 3, 15 December 2008, Pages 302-308

 

3 - No effect of six weeks of treatment with escitalopram on mood in healthy volunteers — Irrespective of genotype for the promoter of the serotonin transporter

Michael Kellner, Cüneyt Demiralay, Christoph Muhtz, Jana Husemann, Wiebke Kölsch, Christoph Hiemke, Alexander Yassouridis and Klaus Wiedemann

Psychiatry Research. Volume 161, Issue 3, 15 December 2008, Pages 339-343

 

GRATIS 3 - Depression in primary care: three key challenges

H LesterA Howe

Postgraduate Medical Journal 2008;84:545-548

3! - Response to a Selective Serotonin Reuptake Inhibitor (Citalopram) in Major Depressive Disorder With Melancholic Features: A STAR*D Report

Patrick J. McGrath, Ahsan Y. Khan, Madhukar H. Trivedi, Jonathan W. Stewart, David W. Morris, Stephen R. Wisniewski, Sachiko Miyahara, Andrew A. Nierenberg, Maurizio Fava, and A. John Rush

J Clin Psychiatry November 18, 2008: e1-e9

 

3 - Risk factors predict post-traumatic stress disorder differently in men and women

Dorte M. Christiansen and Ask Elklit

Annals of General Psychiatry 2008, 7:24

 

3! - Population projection of US adults with lifetime experience of depressive disorder by age and sex from year 2005 to 2050

Moonseong Heo, Christopher F. Murphy, Kevin R. Fontaine, Martha L. Bruce, George S. Alexopoulos

International Journal of Geriatric Psychiatry. Volume 23 Issue 12, Pages 1266 - 1270

 

3 - Polycystic ovary syndrome in women using valproate: A review

Leonilda Bilo; Roberta Meo

Gynecological Endocrinology, Volume 24, Issue 10 2008, pages 562 - 570

 

3! - Partial remission indicates poor functioning and a high level of psychiatric symptoms: A 3-phase 6-year follow-up study on major depression

Heimo Viinamaki;  Jukka Hintikka;  Tommi Tolmunen;  Kirsi Honkalampi;  Kaisa Haatainen; Heli Koivumaa-Honkanen

Nordic Journal of Psychiatry, Volume 62, Issue 6 2008, pages 437 - 443

 

3! - Predictive factors for generalized seizures after deliberate citalopram overdose

W. Stephen Waring, Julie A. Gray & Ann Graham

British Journal of Clinical Pharmacology. Volume 66 Issue 6, Pages 861 - 865

 

3 - Complementary and alternative medicine for perinatal depression

Marlene P. Freeman

Journal of Affective Disorders. Volume 112, Issues 1-3, January 2009, Pages 1-10

 

5 - Aripiprazole monotherapy in the treatment of acute bipolar I mania: A randomized, double-blind, placebo- and lithium-controlled study

P.E. Keck, P.J. Orsulak, A.J. Cutler, R. Sanchez, A. Torbeyns, R.N. Marcus, R.D. McQuade, W.H. Carson and The CN138-135 Study Group

Journal of Affective Disorders. Volume 112, Issues 1-3, January 2009, Pages 36-49

 

3! - The structure of lifetime manic–hypomanic spectrum

G.B. Cassano, M. Mula, P. Rucci, M. Miniati, E. Frank, D.J. Kupfer, A. Oppo, S. Calugi, L. Maggi, R. Gibbons and A. Fagiolini

Journal of Affective Disorders. Volume 112, Issues 1-3, January 2009, Pages 59-70

 

3! - The phenomenology of recurrent brief depression with and without hypomanic features

H. Lövdahl, S. Andersson, T. Hynnekleiv and U.F. Malt

Journal of Affective Disorders. Volume 112, Issues 1-3, January 2009, Pages 151-164

 

3! - Antidepressant treatment normalizes hypoactivity in dorsolateral prefrontal cortex during emotional interference processing in major depression

Christina L. Fales, Deanna M. Barch, Melissa M. Rundle, Mark A. Mintun, Jose Mathews, Abraham Z. Snyder and Yvette I. Sheline

Journal of Affective Disorders. Volume 112, Issues 1-3, January 2009, Pages 206-211

 

3 - Differences between subjective and objective assessments of the utility of Electroconvulsive therapy in patients with bipolar and unipolar depression

K.T. Hallam, D.I. Smith and M. Berk

Journal of Affective Disorders. Volume 112, Issues 1-3, January 2009, Pages 212-218

 

3! - Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: A randomized, parallel group, open-label trial

Jay D. Amsterdam, Chia-Hao Wang, Michelle Shwarz and Justine Shults

Journal of Affective Disorders. Volume 112, Issues 1-3, January 2009, Pages 219-230

 

3 - The role of 5-HTTLPR polymorphism in antidepressant-associated mania in bipolar disorder

Alexandre de Aguiar Ferreira, Fernando Silva Neves, Felipe Filardi da Rocha, Gustavo Silveira e Silva, Marco Aurélio Romano-Silva, Débora Marques Miranda, Luiz De Marco and Humberto Correa

Journal of Affective Disorders. Volume 112, Issues 1-3, January 2009, Pages 267-272

 

3 - FDA Approves New Option to Treat Major Depression

Jun Yan

Psychiatr News November 21, 2008. Volume 43, Number 22, page 2

3 - Intravenous anti-obsessive agents: a review

LN Ravindran, SM Jung, and AV Ravindran

J Psychopharmacol. First published on September 18, 2008

 

5 - Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale

AL Montejo, N Prieto, A Terleira, J Matias, S Alonso, G Paniagua, S Naval, DG Parra, C Gabriel, E Mocaër, and A Portolés

J Psychopharmacol. First published on September 18, 2008

 

3 - Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression

Yukio Ago, Shinsuke Arikawa, Miyuki Yata, Koji Yano, Michikazu Abe, Kazuhiro Takuma and Toshio Matsuda

Neuropharmacology. Volume 55, Issue 8, December 2008, Pages 1355-1363

 

3! - Several major antiepileptic drugs are substrates for human P-glycoprotein

Carlos Luna-Tortós, Maren Fedrowitz and Wolfgang Löscher

Neuropharmacology. Volume 55, Issue 8, December 2008, Pages 1364-1375

 

3 - Anxiety, independent of depressive symptoms, is associated with in-hospital cardiac complications after acute myocardial infarction

Jeff C. Huffman, Felicia A. Smith, Mark A. Blais, James L. Januzzi and Gregory L. Fricchione

Journal of Psychosomatic Research. Volume 65, Issue 6 December 2008, Pages 557-563

 

3! - Mental disorders among persons with diabetes—Results from the World Mental Health Surveys

Elizabeth H.B. Lin, Michael Von Korff and on behalf of the WHO WMH Survey Consortium

Journal of Psychosomatic Research. Volume 65, Issue 6, December 2008, Pages 571-580

 

3 - Clinical evaluation of paroxetine in post-traumatic stress disorder (PTSD): 52-week, non-comparative open-label study for clinical use experience

Yoshiharu Kim, Nozomu Asukai, Takako Konishi, Hiroshi Kato, Hideto Hirotsune, Masaharu Maeda, Hirotaka Inoue, Hiroyasu Narita, and Masaru Iwasaki

Psychiatry and Clinical Neurosciences. Volume 62 Issue 6, Pages 646 - 652

 

3 - A pilot study of clonazepam versus psychodynamic group therapy plus clonazepam in the treatment of generalized social anxiety disorder

Daniela Z. Knijnik, Carlos Blanco, Giovanni Abrahão Salum, Carolina U. Moraes, Clarissa Mombach, Ellen Almeida, Marília Pereira, Atahualpa Strapasson, Gisele G. Manfro and Cláudio L. Eizirik

European Psychiatry. Volume 23, Issue 8, December 2008, Pages 567-574

 

3 - Augmentation strategies for treatment-resistant depression

Carvalho, Andre F; Machado, Juliana Raulino; Cavalcante, Joao L

Current Opinion in Psychiatry. 22(1):7-12, January 2009

3 - Managing unipolar depression in pregnancy

Raudzus, Julia; Misri, Shaila

Current Opinion in Psychiatry. 22(1):13-18, January 2009

3 - Neurosurgical treatment of mood disorders: traditional psychosurgery and the advent of deep brain stimulation

Sachdev, Perminder S; Chen, Xiaohua

Current Opinion in Psychiatry. 22(1):25-31, January 2009

3 - Long-term outcome of anxiety disorders: a review of double-blind studies

Thuile, Jacques; Even, Christian; Rouillon, Frederic

Current Opinion in Psychiatry. 22(1):84-89, January 2009

3 - Current use of benzodiazepines in anxiety disorders

Cloos, Jean-Marc; Ferreira, Valerie

Current Opinion in Psychiatry. 22(1):90-95, January 2009

3 - Comorbidity of adult attention-deficit hyperactivity disorder and bipolar disorder: prevalence and clinical correlates

Lut Tamam, Gonca Karakus and Nurgul Ozpoyraz

European Archives of Clinical Neuroscience. Volume 258, Number 7 / octubre de 2008: 385-393

 

3 - Long-Term Effectiveness of Lithium in Bipolar Disorder: A Multicenter Investigation of Patients With Typical and Atypical Features

Anne Berghöfer, Martin Alda, Mazda Adli, Christopher Baethge, Michael Bauer, Tom Bschor, Tasha Glenn, Paul Grof, Bruno Müller-Oerlinghausen, Janusz Rybakowski, Alexandra Suwalska, and Andrea Pfennig

J Clin Psychiatry November 18, 2008: e1-e9

 

GRATIS 3 - Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine

Inge Sillaber, Markus Panhuysen, Markus S. H. Henniger, Frauke Ohl, Claudia Kühne, Benno Pütz, Thomas Pohl, Jan M. Deussing, Marcelo Paez-Pereda and Florian Holsboer

Psychopharmacology. Volume 200, Number 4 / November 2008: 557-572

 

3 - Effects of 5,7-dihydroxytryptamine lesion of the dorsal raphe nucleus on the antidepressant-like action of tramadol in the unpredictable chronic mild stress in mice

Ipek Yalcin, Stéphanie Coubard, Sylvie Bodard, Sylvie Chalon and Catherine Belzung

Psychopharmacology. Volume 200, Number 4 / November 2008: 497-507

 

3 - Antidepressant activity of curcumin: involvement of serotonin and dopamine system

Shrinivas K. Kulkarni, Mohit Kumar Bhutani and Mahendra Bishnoi

Psychopharmacology. Volume 201, Number 3 / December 2008: 435-442

 

3 - Basal and stress-induced modulation of activity-regulated cytoskeletal associated protein (Arc) in the rat brain following duloxetine treatment

Raffaella Molteni, Francesca Calabrese, Michele Mancini, Giorgio Racagni and Marco A. Riva

Psychopharmacology. Volume 201, Number 2 / December 2008: 285-292

 

3 - Predictors of response to sertraline in patients with major depression

Shigeru Morishita, Toshihiko Kinoshita

Human Psychopharmacology: Clinical and Experimental. Volume 23 Issue 8, Pages 647 - 651

 

3! - Quetiapine augmentation in depressed patients with partial response to antidepressants

James S Olver, Sophie Ignatiadis, Paul Maruff, Graham D Burrows, Trevor R Norman

Human Psychopharmacology: Clinical and Experimental. Volume 23 Issue 8, Pages 653 - 660

 

3 - Addition of risperidone to sertraline improves sertraline-resistant refractory depression without influencing plasma concentrations of sertraline and desmethylsertraline

Reiji Yoshimura, Wakako Umene-Nakano, Nobuhisa Ueda, Atsuko Ikenouchi-Sugita, Hikaru Hori, Jun Nakamura

Human Psychopharmacology: Clinical and Experimental. Volume 23 Issue 8, Pages 707 - 713

 

3! - The Effect of Pain on Outcomes in a Trial of Duloxetine Treatment of Major Depressive Disorder

Lesley M. Arnold;  Adam L. Meyers;  Prabha Sunderajan;  C. Brendan Montano;  Ethan Kass DO;  Madhukar Trivedi; Madelaine M. Wohlreich

Annals of Clinical Psychiatry, Volume 20, Issue 4 November 2008, pages 187 - 193

 

3! - Factors Predicting Reduced Antidepressant Response: Experience with the SNRI Duloxetine in Patients with Major Depression

Robert H. Howland;  Michael G. Wilson;  Susan G. Kornstein;  Anita H. Clayton;  Madhukar H. Trivedi;  Madelaine M. Wohlreich; Maurizio Fava

Annals of Clinical Psychiatry, Volume 20, Issue 4 November 2008, pages 209 - 218

 

3 - Lithium: Bipolar disorder and neurodegenerative diseases Possible cellular mechanisms of the therapeutic effects of lithium

Frederic Marmol

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 32, Issue 8, 12 December 2008, Pages 1761-1771

 

3! - Functional brain asymmetry as a determinative factor in the treatment of depression: Theoretical implications

V.S. Rotenberg

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 32, Issue 8, 12 December 2008, Pages 1772-1777

 

3! - Patterns of mood changes throughout the reproductive cycle in healthy women without premenstrual dysphoric disorders

X. Gonda, T. Telek, G. Juhász, J. Lazary, A. Vargha and G. Bagdy

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 32, Issue 8, 12 December 2008, Pages 1782-1788

 

3! - Interaction between serotonin 5-HT1A receptors and β-endorphins modulates antidepressant response

Ricard Navinés, Rocío Martín-Santos, Esther Gómez-Gil, María J. Martínez de Osaba and Cristòbal Gastó

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 32, Issue 8, 12 December 2008, Pages 1804-1809

 

3! - Reduced efficacy of fluoxetine following MDMA (“Ecstasy”)-induced serotonin loss in rats

Sarah Durkin, Alison Prendergast and Andrew Harkin

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 32, Issue 8, 12 December 2008, Pages 1894-1901

 

3 - Interaction of zinc with antidepressants in the tail suspension test

Mauricio P. Cunha, Daniele G. Machado, Luis E.B. Bettio, Juliano C. Capra and Ana Lúcia S. Rodrigues

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 32, Issue 8, 12 December 2008, Pages 1913-1920

 

3 - The antimanic-like effect of tamoxifen: Behavioural comparison with other PKC-inhibiting and antiestrogenic drugs

Pamela Sabioni, Irinéia P. Baretta, Ester M. Ninomiya, Lianna Gustafson, Ana Lúcia S. Rodrigues and Roberto Andreatini

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 32, Issue 8, 12 December 2008, Pages 1927-1931

 

3 - Pharmacogenetics and the serotonin transporter in late-life depression

Philip Gerretsen & Bruce G Pollock

Expert Opinion on Drug Metabolism & Toxicology. December 2008, Vol. 4, No. 12, Pages 1465-1478

 

3 - Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial

Marianna Mazza, Maria Rosaria Squillacioti, Riccardo Daniele Pecora, Luigi Janiri & Pietro Bria

Expert Opinion on Pharmacotherapy. December 2008, Vol. 9, No. 18, Pages 3145-3149

 

GRATIS 3 - Effectiveness of Long-Term Augmentation with Citalopram to Clomipramine in Treatment-Resistant OCD Patients

Donatella Marazziti, Francesca Golia, Giorgio Consoli, Silvio Presta, Chiara Pfanner, Marina Carlini, Francesco Mungai, and Mario Catena Dell’Osso

CNS Spectr. 2008;13(11):971-976

 

GRATIS 3! - Pregnancy Exposure to Serotonin Reuptake Inhibitors and the Risk of Spontaneous Abortions

Salvatore Gentile

CNS Spectr. 2008;13(11):960-966

 

GRATIS 3 - The Bipolar Spectrum—A Bridge Too Far?

Scott B Patten, Joel Paris

Can J Psychiatry 2008;53(11):762–768

 

GRATIS 3 - Lorazepam-Quetiapine Doses in Manic and Mixed Episodes

Yasser Khazaal, Anne Chatton, and Daniele Zullino

German J Psychiatry 2008; 11: 107-110

 

GRATIS 3 - Drinking Spring Water and Lithium Absorption: A Preliminary Study

Ippei Shiotsuki, Takeshi Terao, Hirochika Ogami, Nobuyoshi Ishii, Reiji Yoshimura and Jun Nakamura

German J Psychiatry 2008; 11: 103-106

 

GRATIS 3! - New and Proposed Drugs for Mood Disorders

Patrick Ying

Primary Psychiatry. 2008;15(12):65-72

 

GRATIS 3! - New and Recent Drugs for Anxiety Disorders

Yujuan Choy, and Franklin R. Schneier

Primary Psychiatry. 2008;15(12):50-56

 

3- Frequency of Stimulant Treatment and of Stimulant-Associated Mania/Hypomania in Bipolar Disorder Patients

Aliza P. Wing and S. Nassir Ghaemi

Psychopharmacol Bull 2008; 41:37-43

.

Regresar a RESÚMENES NOVIEMBRE 2008

.

© 1999-2008 Jorge M Tamayo, MD, BMSS

Creada en Enero 1999

Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA.